PHARMACEUTICAL ECONSULTING A/S: Financial statements 2024
CVR: 30815378
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
PHARMACEUTICAL ECONSULTING A/S (CVR 30815378) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 5,538,003 and a net result of DKK -643,853 compared with DKK -383,631 the year before. That is a decrease of 0.7% compared with the year before. Equity in the 2024 report amounted to DKK 6,219,565. The solvency ratio was 70.6%. The company had 8 employees in the financial year.
- Gross Profit
- DKK 5,538,003
- Profit/Loss
- DKK -643,853
- Equity
- DKK 6,219,565
- Total Assets
- DKK 8,806,139
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 5.5M | -644K | 6.2M | 8 |
| 2023 | - | 5.6M | -384K | 6.9M | 8 |
| 2022 | - | 6.8M | 780K | 7.2M | 8 |
| 2021 | - | 8.3M | 2.4M | 6.5M | 5 |
| 2020 | - | 6.9M | 2.3M | 4M | 4 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2023. Gross profit came to DKK 5,578,646, and the net result was DKK -383,631.
About PHARMACEUTICAL ECONSULTING A/S
PHARMACEUTICAL ECONSULTING A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2007. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Steen Otto Rugaard. The board consists of Pernille Laurberg Rugaard (chair), Hanne Laurberg Olesen and Steen Otto Rugaard. The company is owned by RUGAARD HOLDING ApS. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 6,113,709 and a net result of DKK -1,066,960 compared with DKK -643,853 the year before. Equity in the 2025 report amounted to DKK 5,152,605.